quantisnow
FeedTopReportsPricing
⌘K
Live feed
06:00:00·128d
PRRelease
Traws Pharma Inc. logo

Traws Pharma Reports Positive Interim Clinical Data with Ratutrelvir Versus PAXLOVID™, Shows Activity in PAXLOVID-Ineligible COVID-19 Patients

TRAW· Traws Pharma Inc.
Health Care
Original source

Companies

  • TRAW
    Traws Pharma Inc.
    Health Care

Recent analyst ratings

  • Dec 3UpdateH.C. Wainwright$8.00

Related

  • SEC8d
    SEC Form 10-K filed by Traws Pharma Inc.
  • SEC8d
    Traws Pharma Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR8d
    Traws Pharma Reports Full Year 2025 Results and Provides Business Highlights
  • PR9d
    Traws Pharma Announces Up to $60 Million Private Placement Financing
  • SEC9d
    Traws Pharma Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits
  • INSIDER15d
    SEC Form 4 filed by Parker Charles Nolan
  • INSIDER15d
    SEC Form 3 filed by new insider Parker Charles Nolan
  • SEC23d
    SEC Form NT 10-K filed by Traws Pharma Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022